NCT00877149View on ClinicalTrials.gov

Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

April 30, 2011

Conditions
Compensated Chronic Hepatitis B
Interventions
DRUG

telbivudine/LDT600

Trial Locations (4)

Unknown

Beijing Ditan Hospital, Beijing

First Hospital of Peking University, Beijing

Peking University People's Hospital, Beijing

Ruijin Hospital, Affiliated to 2nd Medical university, Shanghai

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY